839 related articles for article (PubMed ID: 22547072)
1. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.
Ladiwala AR; Litt J; Kane RS; Aucoin DS; Smith SO; Ranjan S; Davis J; Van Nostrand WE; Tessier PM
J Biol Chem; 2012 Jul; 287(29):24765-73. PubMed ID: 22547072
[TBL] [Abstract][Full Text] [Related]
2. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
Wu JW; Breydo L; Isas JM; Lee J; Kuznetsov YG; Langen R; Glabe C
J Biol Chem; 2010 Feb; 285(9):6071-9. PubMed ID: 20018889
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
4. Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.
Romeo M; Stravalaci M; Beeg M; Rossi A; Fiordaliso F; Corbelli A; Salmona M; Gobbi M; Cagnotto A; Diomede L
J Alzheimers Dis; 2017; 57(3):857-871. PubMed ID: 28282805
[TBL] [Abstract][Full Text] [Related]
5. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
Kayed R; Head E; Sarsoza F; Saing T; Cotman CW; Necula M; Margol L; Wu J; Breydo L; Thompson JL; Rasool S; Gurlo T; Butler P; Glabe CG
Mol Neurodegener; 2007 Sep; 2():18. PubMed ID: 17897471
[TBL] [Abstract][Full Text] [Related]
6. Conformation-specific perturbation of membrane dynamics by structurally distinct oligomers of Alzheimer's amyloid-β peptide.
Madhu P; Das D; Mukhopadhyay S
Phys Chem Chem Phys; 2021 Apr; 23(16):9686-9694. PubMed ID: 33908427
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
[TBL] [Abstract][Full Text] [Related]
8. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
9. Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.
Ono K; Condron MM; Teplow DB
J Biol Chem; 2010 Jul; 285(30):23186-97. PubMed ID: 20452980
[TBL] [Abstract][Full Text] [Related]
10. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway.
Lee S; Fernandez EJ; Good TA
Protein Sci; 2007 Apr; 16(4):723-32. PubMed ID: 17327396
[TBL] [Abstract][Full Text] [Related]
11. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
[TBL] [Abstract][Full Text] [Related]
12. Role of water in protein aggregation and amyloid polymorphism.
Thirumalai D; Reddy G; Straub JE
Acc Chem Res; 2012 Jan; 45(1):83-92. PubMed ID: 21761818
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology.
Bett CK; Ngunjiri JN; Serem WK; Fontenot KR; Hammer RP; McCarley RL; Garno JC
ACS Chem Neurosci; 2010 Sep; 1(9):608-26. PubMed ID: 22778850
[TBL] [Abstract][Full Text] [Related]
14. Glucose directs amyloid-beta into membrane-active oligomers.
Kedia N; Almisry M; Bieschke J
Phys Chem Chem Phys; 2017 Jul; 19(27):18036-18046. PubMed ID: 28671211
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer.
Ma B; Nussinov R
J Biol Chem; 2010 Nov; 285(47):37102-10. PubMed ID: 20847046
[TBL] [Abstract][Full Text] [Related]
16. α-synuclein-assisted oligomerization of β-amyloid (1-42).
Chau E; Kim JR
Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
[TBL] [Abstract][Full Text] [Related]
17. Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways.
Ladiwala AR; Dordick JS; Tessier PM
J Biol Chem; 2011 Feb; 286(5):3209-18. PubMed ID: 21098486
[TBL] [Abstract][Full Text] [Related]
18. Structure-neurotoxicity relationships of amyloid beta-protein oligomers.
Ono K; Condron MM; Teplow DB
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14745-50. PubMed ID: 19706468
[TBL] [Abstract][Full Text] [Related]
19. Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.
Ladiwala AR; Mora-Pale M; Lin JC; Bale SS; Fishman ZS; Dordick JS; Tessier PM
Chembiochem; 2011 Jul; 12(11):1749-58. PubMed ID: 21671331
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
